Three areas of genomic medicine benefiting from the sequencing tech revolution

Published: 14-Apr-2025
Cell & Gene Therapy

One of the great challenges of modern medicine, despite significant advances in many therapeutic areas, is that some diseases remain stubbornly difficult to treat. Neil Ward, Vice President, EMEA, at PacBio, investigates

You need to be a subscriber to read this article.
Click here to find out more.

For example, breakthroughs have continued to be elusive in certain types of cancer, neurological conditions such as Parkinson’s and Alzheimer’s, and a wide array of rare diseases.

Genomic medicine is now changing that. Our ever-expanding knowledge and application of all things -omics is fundamentally shifting research towards the underlying causes of disease for each individual and transforming the landscape of treatment options. 

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.
  • Companies:
  • PacBio
See more

You may also like

Cell & Gene Therapy

SPT Labtech and Cavendish combine technologies to improve the cell-based assay design process

Read more
By combining technologies, the companies hope to optimise the cell assay development workflow with automation

Trending Articles

  1. SPT Labtech and Cavendish combine technologies to improve the cell-based assay design process By combining technologies, the companies hope to optimise the cell assay development workflow with automation
  2. Univercells and Repligen join forces to optimise the real-time monitoring of biologic production By performing real-time monitoring in bioreactors, the companies will eliminate the need for manual nutrient testing when growing cell cultures
  3. Recombinant versus synthetic peptide synthesis: the perks and drawbacks Since the introduction of novel peptide drugs into the market, the demand for polypeptide manufacturing has significantly increased, reports Dr Philipp Markolin
  4. Opening new doors to precision medicine with single-stranded DNA (ssDNA): part II In the second part of this article, the benefits of ssDNA in terms of efficient cellular uptake and stability, the application of self-folding nanocarriers for gene delivery and mechanisms of action are discussed, along with a forward-thinking review of future perspectives and challenges
  5. Opening new doors to precision medicine with single-stranded DNA (ssDNA): part I In this two-part article, the science behind ssDNA manufacturing is explored, along with the innovations that are enhancing the therapeutic benefits of ssDNA-derived constructs. A comparative analysis of traditional double-stranded DNA (dsDNA) and other nucleic acid-based methods is also included

Upcoming event

POWTECH

23-25 September 2025 | Exhibition | Nuremberg, Germany See all

You may also like

Cell & Gene Therapy

SPT Labtech and Cavendish combine technologies to improve the cell-based assay design process

By combining technologies, the companies hope to optimise the cell assay development workflow with automation
Manufacturing

Univercells and Repligen join forces to optimise the real-time monitoring of biologic production

By performing real-time monitoring in bioreactors, the companies will eliminate the need for manual nutrient testing when growing cell cultures
Cell & Gene Therapy

The challenges and trends in gene therapy

Three perspectives on the challenges and trends in gene therapy
Manufacturing

Andelyn Biosciences adds Stanton Lab CNS Capsids to AAV Curator Platform

Andelyn Biosciences expands AAV Curator® Platform offering to include Stanton Lab CNS Capsids through a license agreement from the Broad Institute of MIT and Harvard
Manufacturing

Thermo Fisher teams up with Xcellbio to further cell and gene therapy research

The pair will focus on Treg and TIL research, with the intention of developing therapeutics for autoimmune and solid tumour diseases
Manufacturing

Ensuring cGMP compliance in cell and gene therapy manufacturing

By adhering to GMP principles, manufacturers can mitigate risks, streamline processes, and ensure that their products meet the highest standards of safety and efficacy
Manufacturing

Terumo's Quantum Platform integrates CAR-T production, protocol states

The quantum platform unifies T cell activation, lentiviral vector transduction and CAR-T expansion to streamline the manufacturing process
Subscribe now